Sandra Levy
ARTICLES BY THIS AUTHOR
- 3/29/2021
Industry applauds Biden’s expansion of federal pharmacy partnership
The Biden administration is more than doubling the number of pharmacies in the Federal Retail Pharmacy Program from 17,000 to nearly 40,000. - 3/29/2021
NACDS lauds legislation to protect consumers, retailers in e-commerce marketplaces
The INFORM Consumers Act is intended to crack down on organized retail crime, and promote the safety of customers and retailers. - 3/29/2021
Aurobindo intros generic Atripla, gets FDA nod for Arava
The company's latest generics offer alternatives for branded drugs indicated for HIV, as well as rheumatoid arthritis. - 3/29/2021
Aurobindo intros generics of Truvada, Minocin
The company's latest launches offer generics of a popular HIV and PrEP drug, as well as a common antibiotic. - 3/28/2021
NeedyMeds' drug discount card exceeds $300M in savings
NeedyMeds has information on hundreds of programs that offer free medications to those who qualify. - 3/28/2021
New York launches nation's first ‘vaccine passport’
The Excelsior Pass — which helps confirm a person's proof of vaccination or negative COVID-19 test results — is expected to be accepted at dozens of events, arts and entertainment venues in New York. - 3/28/2021
GSK, Vir seek emergency use OK for COVID-19 therapy
Earlier this month, GSK and Vir found that their experimental COVID treatment, VIR-7831, reduced the risk of hospitalization and deaths among patients by 85%, based on interim data from a study. - 3/25/2021
Xiromed launches generic Prilosec
Prilosec delayed-release capsules and its generics had a market value of $104.5 million for the 12-month period ended January 2021, according to IQVIA. - 3/25/2021
Trial to study delivering AstraZeneca COVID-19 vaccine as a nasal spray
An AstraZeneca nasal spray trial could start as early as next week, according to a Financial Times report. - 3/25/2021
FDA clears new indication, formulation for Astellas’ Myrbetriq
Astellas is bringing forward a new treatment option for children impacted by neurogenic detrusor overactivity, a bladder dysfunction related to neurological impairment.
